OncoZenge: SEK30.2m investment agreement with Yangtian Pharma - Redeye
Bildkälla: Stockfoto

OncoZenge: SEK30.2m investment agreement with Yangtian Pharma - Redeye

Redeye leaves a comment following OncoZenge’s announcement yesterday of having entered a SEK30.2m investment agreement with the Chinese pharmaceutical company Yangtian Pharma. We are encouraged to see that the company has secured essential funding and believe that this agreement marks a significant milestone.

Redeye leaves a comment following OncoZenge’s announcement yesterday of having entered a SEK30.2m investment agreement with the Chinese pharmaceutical company Yangtian Pharma. We are encouraged to see that the company has secured essential funding and believe that this agreement marks a significant milestone.
Börsvärldens nyhetsbrev
ANNONSER